| Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ... Journal of Thoracic Oncology 5 (10), 1706-1713, 2010 | 362 | 2010 |
| Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer L Yang, Y Chen, T Cui, T Knösel, Q Zhang, KF Albring, O Huber, ... Carcinogenesis 33 (10), 1863-1870, 2012 | 162 | 2012 |
| DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer T Cui, Y Chen, L Yang, T Knösel, K Zöller, O Huber, I Petersen British journal of cancer 104 (6), 1013-1019, 2011 | 88 | 2011 |
| The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer T Cui, Y Chen, L Yang, T Knösel, O Huber, M Pacyna-Gengelbach, ... Carcinogenesis 33 (12), 2326-2333, 2012 | 76 | 2012 |
| MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways Estrada-Bernal A, C M, H SJ, Y L, M MA, K S, M D, C A, W TM Cell Cycle, 2015 | 71 | 2015 |
| Human complement factor H is a novel diagnostic marker for lung adenocarcinoma T Cui, Y Chen, T Knösel, L Yang, K Zöller, K Galler, A Berndt, M Mihlan, ... International journal of oncology 39 (1), 161-168, 2011 | 69 | 2011 |
| Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma L Yang, Y Chen, T Cui, T Knösel, Q Zhang, C Geier, D Katenkamp, ... Human pathology 43 (9), 1463-1470, 2012 | 67 | 2012 |
| The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer Y Chen, T Cui, L Yang, M Mireskandari, T Knoesel, Q Zhang, ... Oncology 80 (5-6), 333-340, 2011 | 65 | 2011 |
| Expression of desmogleins 1–3 and their clinical impacts on human lung cancer F Saaber, Y Chen, T Cui, L Yang, M Mireskandari, I Petersen Pathology-Research and Practice 211 (3), 208-213, 2015 | 63 | 2015 |
| miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma T Cui, EH Bell, J McElroy, AP Becker, PM Gulati, M Geurts, N Mladkova, ... Oncogene 38 (16), 2923-2936, 2019 | 57 | 2019 |
| The role of desmosomes in carcinogenesis G Zhou, L Yang, A Gray, AK Srivastava, C Li, G Zhang, T Cui OncoTargets and therapy, 4059-4063, 2017 | 55 | 2017 |
| IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation Y Chen, T Cui, T Knösel, L Yang, K Zöller, I Petersen Lung Cancer 73 (1), 38-44, 2011 | 50 | 2011 |
| HOPX is methylated and exerts tumour‐suppressive function through Ras‐induced senescence in human lung cancer Y Chen, L Yang, T Cui, M Pacyna‐Gengelbach, I Petersen The Journal of pathology 235 (3), 397-407, 2015 | 47 | 2015 |
| Diagnostic and prognostic impact of desmocollins in human lung cancer T Cui, Y Chen, L Yang, M Mireskandari, T Knösel, Q Zhang, LH Kohler, ... Journal of clinical pathology 65 (12), 1100-1106, 2012 | 47 | 2012 |
| Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair L Yang, C Shen, A Estrada-Bernal, R Robb, M Chatterjee, N Sebastian, ... Nucleic acids research 49 (19), 11067-11082, 2021 | 46 | 2021 |
| Non-small-cell lung cancer regression by siRNA delivered through exosomes that display EGFR RNA aptamer Z Li, L Yang, H Wang, DW Binzel, TM Williams, P Guo Nucleic acid therapeutics 31 (5), 364-374, 2021 | 46 | 2021 |
| Inhibiting BRAF Oncogene–Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand … R Robb, L Yang, C Shen, AR Wolfe, A Webb, X Zhang, M Vedaie, M Saji, ... Clinical Cancer Research 25 (15), 4749-4760, 2019 | 44 | 2019 |
| Wee1 kinase inhibitor AZD1775 effectively sensitizes esophageal cancer to radiotherapy L Yang, C Shen, CJ Pettit, T Li, AJ Hu, ED Miller, J Zhang, SH Lin, ... Clinical Cancer Research 26 (14), 3740-3750, 2020 | 41 | 2020 |
| High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event T Knösel, Y Chen, A Altendorf-Hofmann, C Danielczok, M Freesmeyer, ... Journal of cancer research and clinical oncology 138, 397-403, 2012 | 38 | 2012 |
| LCL161, a SMAC-mimetic, preferentially radiosensitizes human papillomavirus–negative head and neck squamous cell carcinoma L Yang, B Kumar, C Shen, S Zhao, D Blakaj, T Li, M Romito, TN Teknos, ... Molecular cancer therapeutics 18 (6), 1025-1035, 2019 | 32 | 2019 |
Tiantian Cuithe ohio state universityEmail confirmado em osumc.edu
